Not only does PTEN genomic deletion have a poorer outcome in hormone refractory prostate cancer [43], the expression of the ETS-related proto-oncogene (ERG) also plays a crucial role in the ocnogenic mechanism and progression of PCa [44]. This evidence concerns the gene ERG and posterior cortical atrophy.